✦ LIBER ✦

Cost Effectiveness of Chemoprevention for Prostate Cancer with Dutasteride in a High-Risk Population Based on Results from the REDUCE Clinical Trial

✍ Scribed by Kattan, Michael W.; Earnshaw, Stephanie R.; McDade, Cheryl L.; Black, Libby K.; Andriole, Gerald L.

Book ID: 121639462
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2011
Tongue: English
Weight: 264 KB
Volume: 9
Category: Article
ISSN: 1175-5652
DOI: 10.2165/11592200-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN76 COST-EFFECTIVENESS OF CHEMOPREVENT

PCN76 COST-EFFECTIVENESS OF CHEMOPREVENTION WITH DUTASTERIDE BASED ON RESULTS FROM THE REDUCE CLINICAL TRIAL

✍ SR Earnshaw; CL McDade; L Black; MW Kattan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

The Effect of Dutasteride on the Usefuln

The Effect of Dutasteride on the Usefulness of Prostate Specific Antigen for the Diagnosis of High Grade and Clinically Relevant Prostate Cancer in Men With a Previous Negative Biopsy: Results From the REDUCE Study

✍ Andriole, Gerald L.; Bostwick, David; Brawley, Otis W.; Gomella, Leonard; Marber 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 147 KB

PDB25 COST-EFFECTIVENESS OF DETEMIR VERS

PDB25 COST-EFFECTIVENESS OF DETEMIR VERSUS NPH FOR TYPE 1 DIABETES PATIENTS TREATED WITH BASAL-BOLUS THERAPY IN A BELGIUM SETTING, A MODELING EVALUATION BASED ON RESULTS FROM A META-ANALYSIS OFTHREE CLINICAL TRIALS

✍ H Scheijbeler; M Aagren; S Nielsen; G Goodall; R Kotchie; WJ Valentine 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Commentary on “Mortality results from th

Commentary on “Mortality results from the Göteborg randomized population-based prostate-cancer screening trial”: Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Pihl CG, Stranne J, Holmberg E, Lilja H, Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Göteborg, Sweden. Lancet Oncol 2010;11:725–32, Comment in 702–3 (Epub 2010 Jul 2) Nat Rev Urol 2010;7:415

✍ Joseph A. Smith 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Re: Liam Bourke, Stephen Gilbert, Richar

Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle Changes for Improving Disease-specific Quality of Life in Sedentary Men on Long-term Androgen-Deprivation Therapy for Advanced Prostate Cancer: A Randomised Controlled Trial. Eur Urol 2014;65:865–72;Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A Multicentre Year-long Randomised Controlled Trial of Exercise Training Targeting Physical Functioning in Men with Prostate Cancer Previously Treated with Androgen Suppression and Radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856–64;Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O’Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation Therapy and Diabetes Control Among Diabetic Men with Prostate Cancer. Eur Urol 2014;65:816–24;Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study. Eur Urol 2014;65:704–9

✍ Goonewardene, Sanchia S.; Persad, Raj; Young, Annie; Makar, Adel 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 144 KB